FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2026
Voltar para busca
Dado oficial do USPTO
TENULI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
20
Atualização mais recente
07/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
11/07/2025
Data de registro
07/04/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/04/2026
Última transação
07/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
IE
Examinador
CLARK, ANDREW T
Unidade examinadora
L70
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Bausch Health Ireland Limited
Representantes
Jeremy Blackowicz Bausch Health Companies
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of autoimmune conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of blood conditions, diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of conditions, diseases, and disorders of the central and peripheral nervous system; pharmaceutical preparations for the prevention and treatment of dermatological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of endocrine conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of gastrointestinal conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of hepatic conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of immunological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases; pharmaceutical preparations for the prevention and treatment of inflammatory conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of metabolic conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of muscular conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of neurological conditions, diseases, and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the prevention and treatment of psychiatric conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of respiratory and pulmonary conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of renal conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of urological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of viral diseases.
Publicações
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/04/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/02/2026
PUBO
PUBLISHED FOR OPPOSITION
17/02/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/02/2026
RFNT
REFUSAL PROCESSED BY IB
29/01/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/01/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/01/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/01/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/01/2026
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/01/2026
RFRR
REFUSAL PROCESSED BY MPU
09/01/2026
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
18/12/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/12/2025
CNRT
NON-FINAL ACTION WRITTEN
02/12/2025
DOCK
ASSIGNED TO EXAMINER
01/12/2025
MAFR
APPLICATION FILING RECEIPT MAILED
15/08/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/08/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
14/08/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TENULI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.